We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Boosting the Efficacy of A Key Cancer Treatment

News   Feb 21, 2017 | Original story from Sbarro Health Research Organization

 
Boosting the Efficacy of A Key Cancer Treatment

MicroRNA-125a-5p is a downstream effector of sorafenib in its antiproliferative activity toward human hepatocellular carcinoma cells. Credit: Sbarro Health Research Organization

 
 
 

RELATED ARTICLES

Making Resistant Melanomas Susceptible to Immunotherapy

News

A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.

READ MORE

Powerful Microscope Reveals Motility Nanoscaffold

News

Using one of the most powerful microscopes in the world, scientists have identified a dense, dynamic and disorganized actin filament nanoscaffold that is induced in response to a molecular signal.

READ MORE

Targeting Tumor-infiltrating Immune Cells to Get Them to Fight

News

A team of Vanderbilt University bioengineers designed a nanoscale particle that targets tumor-infiltrating immune cells, flipping on a switch that tells them to start fighting.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE